BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20659064)

  • 1. Commentary on Vemer et al. (2010): when is smoking cessation really cost-effective?
    Salize HJ
    Addiction; 2010 Jun; 105(6):1098-9. PubMed ID: 20659064
    [No Abstract]   [Full Text] [Related]  

  • 2. Smoking treatment interventions and policies to promote their use: a critical review.
    Friend K; Levy DT
    Nicotine Tob Res; 2001 Nov; 3(4):299-310. PubMed ID: 11694197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buproprion, public funding, and smoking cessation.
    Bloomfield A
    N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759
    [No Abstract]   [Full Text] [Related]  

  • 4. A cost-benefit analysis of smoking cessation programs during the first trimester of pregnancy for the prevention of low birthweight.
    Hueston WJ; Mainous AG; Farrell JB
    J Fam Pract; 1994 Oct; 39(4):353-7. PubMed ID: 7931114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's needed for personalized therapy in smoking cessation.
    Epstein RS
    Clin Pharmacol Ther; 2008 Sep; 84(3):309-10. PubMed ID: 18714320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression.
    Barnett PG; Wong W; Hall S
    Addiction; 2008 May; 103(5):834-40. PubMed ID: 18412763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking cessation as IGeL procedure. Cost effective for physician and patient].
    Hering T
    MMW Fortschr Med; 2002 May; 144(18):52. PubMed ID: 12422709
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
    Nielsen K; Fiore MC
    Prev Med; 2000 Mar; 30(3):209-16. PubMed ID: 10684744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of a family physician delivered smoking cessation program.
    Buck DJ; Richmond RL; Mendelsohn CP
    Prev Med; 2000 Dec; 31(6):641-8. PubMed ID: 11133329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database.
    Olsen KR; Bilde L; Juhl HH; Kjaer NT; Mosbech H; Evald T; Rasmussen M; Hiladakis H
    Eur J Health Econ; 2006 Dec; 7(4):255-64. PubMed ID: 16816946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness of the methods of smoking cessation].
    Plans P; Navas E; Tarín A; Rodríguez G; Galí N; Gayta R; Taberner JL; Salleras L
    Med Clin (Barc); 1995 Jan; 104(2):49-54. PubMed ID: 7869779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Web programs can be helpful, cost-effective way to stop smoking.
    Mayo Clin Womens Healthsource; 2009 Dec; 13(12):3. PubMed ID: 19881446
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation of smoking cessation interventions: have we overlooked something].
    Trapero-Bertran M
    Arch Bronconeumol; 2009 May; 45(5):209-11. PubMed ID: 19395140
    [No Abstract]   [Full Text] [Related]  

  • 18. Value to smokers of improved cessation products: evidence from a willingness-to-pay survey.
    Busch S; Falba T; Duchovny N; Jofre-Bonet M; O'Malley S; Sindelar J
    Nicotine Tob Res; 2004 Aug; 6(4):631-9. PubMed ID: 15370159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.